Literature DB >> 20457871

Systemic autoimmunity and defective Fas ligand secretion in the absence of the Wiskott-Aldrich syndrome protein.

Nikolay P Nikolov1, Masaki Shimizu, Sophia Cleland, Daniel Bailey, Joseph Aoki, Ted Strom, Pamela L Schwartzberg, Fabio Candotti, Richard M Siegel.   

Abstract

Autoimmunity is a surprisingly common complication of primary immunodeficiencies, yet the molecular mechanisms underlying this clinical observation are not well understood. One widely known example is provided by Wiskott-Aldrich syndrome (WAS), an X-linked primary immunodeficiency disorder caused by mutations in the gene encoding the WAS protein (WASp) with a high incidence of autoimmunity in affected patients. WASp deficiency affects T-cell antigen receptor (TCR) signaling and T-cell cytokine production, but its role in TCR-induced apoptosis, one of the mechanisms of peripheral immunologic tolerance, has not been investigated. We find that WASp-deficient mice produce autoantibodies and develop proliferative glomerulonephritis with immune complex deposition as they age. We also find that CD4(+) T lymphocytes from WASp-deficient mice undergo reduced apoptosis after restimulation through the TCR. While Fas-induced cell death is normal, WASp deficiency affects TCR-induced secretion of Fas ligand (FasL) and other components of secretory granules by CD4(+) T cells. These results describe a novel role of WASp in regulating TCR-induced apoptosis and FasL secretion and suggest that WASp-deficient mice provide a good model for the study of autoimmune manifestations of WAS and the development of more specific therapies for these complications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20457871      PMCID: PMC2918330          DOI: 10.1182/blood-2009-08-237560

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  Cutting edge: the Wiskott-Aldrich syndrome protein is required for efficient phagocytosis of apoptotic cells.

Authors:  Y Leverrier; R Lorenzi; M P Blundell; P Brickell; C Kinnon; A J Ridley; A J Thrasher
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

Review 2.  Secretory lysosomes.

Authors:  Emma J Blott; Gillian M Griffiths
Journal:  Nat Rev Mol Cell Biol       Date:  2002-02       Impact factor: 94.444

3.  Apoptosis-inducing membrane vesicles. A novel agent with unique properties.

Authors:  S Jodo; S Xiao; A Hohlbaum; D Strehlow; A Marshak-Rothstein; S T Ju
Journal:  J Biol Chem       Date:  2001-08-23       Impact factor: 5.157

4.  Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome.

Authors:  G Ménasché; E Pastural; J Feldmann; S Certain; F Ersoy; S Dupuis; N Wulffraat; D Bianchi; A Fischer; F Le Deist; G de Saint Basile
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

5.  Wasp recruitment to the T cell:APC contact site occurs independently of Cdc42 activation.

Authors:  J L Cannon; C M Labno; G Bosco; A Seth; M H McGavin; K A Siminovitch; M K Rosen; J K Burkhardt
Journal:  Immunity       Date:  2001-08       Impact factor: 31.745

6.  Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells.

Authors:  R Rengan; H D Ochs; L I Sweet; M L Keil; W T Gunning; N A Lachant; L A Boxer; G M Omann
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

7.  The Wiskott-Aldrich syndrome protein acts downstream of CD2 and the CD2AP and PSTPIP1 adaptors to promote formation of the immunological synapse.

Authors:  Karen Badour; Jinyi Zhang; Fabio Shi; Mary K H McGavin; Vik Rampersad; Lynne A Hardy; Deborah Field; Katherine A Siminovitch
Journal:  Immunity       Date:  2003-01       Impact factor: 31.745

8.  Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses.

Authors:  Jordan S Orange; Narayanaswamy Ramesh; Eileen Remold-O'Donnell; Yoji Sasahara; Louise Koopman; Michael Byrne; Francisco A Bonilla; Fred S Rosen; Raif S Geha; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

9.  Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients.

Authors:  Sophie Dupuis-Girod; Jacques Medioni; Elie Haddad; Pierre Quartier; Marina Cavazzana-Calvo; Françoise Le Deist; Geneviève de Saint Basile; Jean Delaunay; Klaus Schwarz; Jean-Laurent Casanova; Stephane Blanche; Alain Fischer
Journal:  Pediatrics       Date:  2003-05       Impact factor: 7.124

10.  Fas ligand is targeted to secretory lysosomes via a proline-rich domain in its cytoplasmic tail.

Authors:  E J Blott; G Bossi; R Clark; M Zvelebil; G M Griffiths
Journal:  J Cell Sci       Date:  2001-07       Impact factor: 5.285

View more
  27 in total

1.  NF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression.

Authors:  Feiyan Liu; Kankana Bardhan; Dafeng Yang; Muthusamy Thangaraju; Vadivel Ganapathy; Jennifer L Waller; Georgia B Liles; Jeffrey R Lee; Kebin Liu
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  Development of IgA nephropathy-like glomerulonephritis associated with Wiskott-Aldrich syndrome protein deficiency.

Authors:  M Shimizu; N P Nikolov; K Ueno; K Ohta; R M Siegel; A Yachie; F Candotti
Journal:  Clin Immunol       Date:  2011-10-19       Impact factor: 3.969

3.  Defective inhibition of B-cell proliferation by Wiskott-Aldrich syndrome protein-deficient regulatory T cells.

Authors:  Marsilio Adriani; Krysten A Jones; Toru Uchiyama; Martha R Kirby; Christopher Silvin; Stacie M Anderson; Fabio Candotti
Journal:  Blood       Date:  2011-04-22       Impact factor: 22.113

4.  B cell-intrinsic deficiency of the Wiskott-Aldrich syndrome protein (WASp) causes severe abnormalities of the peripheral B-cell compartment in mice.

Authors:  Mike Recher; Siobhan O Burns; Miguel A de la Fuente; Stefano Volpi; Carin Dahlberg; Jolan E Walter; Kristin Moffitt; Divij Mathew; Nadine Honke; Philipp A Lang; Laura Patrizi; Hervé Falet; Marton Keszei; Masayuki Mizui; Eva Csizmadia; Fabio Candotti; Kari Nadeau; Gerben Bouma; Ottavia M Delmonte; Francesco Frugoni; Angela B Ferraz Fomin; David Buchbinder; Emma Maria Lundequist; Michel J Massaad; George C Tsokos; John Hartwig; John Manis; Cox Terhorst; Raif S Geha; Scott Snapper; Karl S Lang; Richard Malley; Lisa Westerberg; Adrian J Thrasher; Luigi D Notarangelo
Journal:  Blood       Date:  2012-02-01       Impact factor: 22.113

Review 5.  Harnessing programmed cell death as a therapeutic strategy in rheumatic diseases.

Authors:  Madhu Ramaswamy; Min Deng; Richard M Siegel
Journal:  Nat Rev Rheumatol       Date:  2011-02-01       Impact factor: 20.543

6.  Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome.

Authors:  Alexander Astrakhan; Blythe D Sather; Byoung Y Ryu; Socheath Khim; Swati Singh; Stephanie Humblet-Baron; Hans D Ochs; Carol H Miao; David J Rawlings
Journal:  Blood       Date:  2012-03-19       Impact factor: 22.113

Review 7.  Wiskott-Aldrich Syndrome at the nexus of autoimmune and primary immunodeficiency diseases.

Authors:  Sophia Y Cleland; Richard M Siegel
Journal:  FEBS Lett       Date:  2011-10-25       Impact factor: 4.124

8.  H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance.

Authors:  Amy V Paschall; Dafeng Yang; Chunwan Lu; Jeong-Hyeon Choi; Xia Li; Feiyan Liu; Mario Figueroa; Nicholas H Oberlies; Cedric Pearce; Wendy B Bollag; Asha Nayak-Kapoor; Kebin Liu
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

9.  Abnormalities of follicular helper T-cell number and function in Wiskott-Aldrich syndrome.

Authors:  Xuan Zhang; Rongxin Dai; Wenyan Li; Hongyi Zhao; Yongjie Zhang; Lina Zhou; Hongqiang Du; Guangjin Luo; Junfeng Wu; Linlin Niu; Yunfei An; Zhiyong Zhang; Yuan Ding; Wenxia Song; Chaohong Liu; Xiaodong Zhao
Journal:  Blood       Date:  2016-05-11       Impact factor: 22.113

10.  Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer.

Authors:  Xiaolin Hu; Kankana Bardhan; Amy V Paschall; Dafeng Yang; Jennifer L Waller; Mary Anne Park; Asha Nayak-Kapoor; Thomas A Samuel; Scott I Abrams; Kebin Liu
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.